According to Jefferies, Merck & Co MRK is upgraded to Buy.
Jefferies said that the PT of $37 is based on placing its 2012E EPS estimate on a 10%-15% discount to the US market. “We see the recent weakness as an excellent opportunity to buy the shares.”
Merck & Co closed yesterday at $29.94.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in